Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 9
Submit an article Journal homepage
264
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320

William TownsendCancer Research UK and University College London Cancer Trials Centre, London, UK;
,
Rod J. JohnsonThe Leeds Teaching Hospitals NHS Trust, Leeds, UK;
,
Bryson T. PottingerRoyal Cornwall Hospitals NHS Trust, Truro, UK;
,
Nicholas CounsellCancer Research UK and University College London Cancer Trials Centre, London, UK;
,
Paul SmithCancer Research UK and University College London Cancer Trials Centre, London, UK;
,
Humra ChadwickCancer Research UK and University College London Cancer Trials Centre, London, UK;
,
Katy EvansDepartment of Haematology, Royal Devon and Exeter NHS Foundation Trust, Exeter, DevonEX2 5AD, UK
,
Caroline WickhamDepartment of Haematology, Royal Devon and Exeter NHS Foundation Trust, Exeter, DevonEX2 5AD, UK
,
Claudius E RudinDepartment of Haematology, Royal Devon and Exeter NHS Foundation Trust, Exeter, DevonEX2 5AD, UKCorrespondence[email protected]
& On behalf of the UK NCRI Lymphoma Clinical Studies Group show all
Pages 2232-2234 | Received 11 Jul 2015, Accepted 15 Dec 2015, Published online: 22 Mar 2016

References

  • Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002;13:140–149.
  • Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31:240–246.
  • Mourad N, Mounier N, Brière J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111:4463–4470.
  • Smith A, Roman E, Howell D, et al. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol. 2010;148:739–753.
  • Mak V, Hamm J, Chhanabhai M, et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol. 2013;31:1970–1976.
  • Delfau-Larue MH, de Leval L, Joly B, et al. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica. 2012;97:1594–1602.
  • Ong ST, Koeppen H, Larson RA, et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine. Blood. 1996;88:2354–2355.
  • Tsatalas C, Margaritis D, Pantelidou D, et al. Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol. 2003;109:110.
  • Hallek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet. 2010;376:1164–1174.
  • Dogan A, Ngu LS, Ng SH, et al. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia. 2005;19:873–875.
  • Ramasamy K, Lim Z, Pagliuca A, et al. Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica. 2006;91:ECR44.
  • Gottardi M, Danesin C, Canal F, et al. Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation. Leuk Lymphoma. 2008;49: 1836–1838.
  • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.
  • Advani R, Warnke R, Sikic BI, et al. Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol. 1997;8:601–603.
  • Gerlando Q, Barbera V, Ammatuna E, et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone. Haematologica. 2000;85:880–881.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.